-
1
-
-
16644382086
-
The clinical progress of chemotherapy in non-small cell lung cancer
-
Liao M.L, Cheng B.J, The clinical progress of chemotherapy in non-small cell lung cancer. Chin J Tuberculosis Resp Dis, 2004; 27:480-482.
-
(2004)
Chin J Tuberculosis Resp Dis
, vol.27
, pp. 480-482
-
-
Liao, M.L.1
Cheng, B.J.2
-
2
-
-
34047249406
-
Anti-inflammatory, analgesic and antipyretic activities of the extract of gamboge from Garcinia hanburyi Hook
-
Panthong A, Norkaew P, Kanjanapothi D, Taesotikul T, Anantachoke N, Reutrakul V. Anti-inflammatory, analgesic and antipyretic activities of the extract of gamboge from Garcinia hanburyi Hook. J Ethnopharmacol 2007; 111:335-340.
-
(2007)
J Ethnopharmacol
, vol.111
, pp. 335-340
-
-
Panthong, A.1
Norkaew, P.2
Kanjanapothi, D.3
Taesotikul, T.4
Anantachoke, N.5
Reutrakul, V.6
-
3
-
-
28244453251
-
Effect of gambogic acid on the hemopoietic and immune functions in experimental animals
-
Guo ZL, Wu QL, You ZQ, Yu QD, Zhang GQ. Effect of gambogic acid on the hemopoietic and immune functions in experimental animals. Chin J Nat Med 2003; 1:229-232.
-
(2003)
Chin J Nat Med
, vol.1
, pp. 229-232
-
-
Guo, Z.L.1
Wu, Q.L.2
You, Z.Q.3
Yu, Q.D.4
Zhang, G.Q.5
-
4
-
-
24744435348
-
A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid
-
Kasibhatla S, Jessen KA, Maliartchouk S, Wang JY, English NM, Drewe J, et al. A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid. Proc Natl Acad Sci USA. 2005; 102:12095-12100.
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 12095-12100
-
-
Kasibhatla, S.1
Jessen, K.A.2
Maliartchouk, S.3
Wang, J.Y.4
English, N.M.5
Drewe, J.6
-
5
-
-
46449099079
-
Microtubule depolymerization and phosphorylation of c-Jun N-terminal kinase-1 and p38 were involved in gambogic acid induced cell cycle arrest and apoptosis in human breast carcinoma MCF-7 cells
-
Chen J, Gu HY, Lu N, Yang Y, Liu W, Qi Q, et al. Microtubule depolymerization and phosphorylation of c-Jun N-terminal kinase-1 and p38 were involved in gambogic acid induced cell cycle arrest and apoptosis in human breast carcinoma MCF-7 cells. Life Sci. 2008; 83:103-109.
-
(2008)
Life Sci
, vol.83
, pp. 103-109
-
-
Chen, J.1
Gu, H.Y.2
Lu, N.3
Yang, Y.4
Liu, W.5
Qi, Q.6
-
6
-
-
33745698235
-
Repression of telomerase reverse transcriptase mRNA and hTERT promoter by gambogic acid in human gastric carcinoma cells.Cancer
-
Yu J, Guo QL, You QD, Lin SS, Li Z, Gu HY, et al Repression of telomerase reverse transcriptase mRNA and hTERT promoter by gambogic acid in human gastric carcinoma cells.Cancer Chemother Pharmacol. 2006; 58:434-443.
-
(2006)
Chemother Pharmacol
, vol.58
, pp. 434-443
-
-
Yu, J.1
Guo, Q.L.2
You, Q.D.3
Lin, S.S.4
Li, Z.5
Gu, H.Y.6
-
7
-
-
38949176773
-
Inhibition of glioblastoma growth and angiogenesis by gambogic acid: An in vitro and in vivo study
-
Qiang L, Yang Y, You QD, Ma YJ, Yang L, Nie FF, et al. Inhibition of glioblastoma growth and angiogenesis by gambogic acid: An in vitro and in vivo study. Biochem Pharmacol. 2008; 75:1083-1092.
-
(2008)
Biochem Pharmacol
, vol.75
, pp. 1083-1092
-
-
Qiang, L.1
Yang, Y.2
You, Q.D.3
Ma, Y.J.4
Yang, L.5
Nie, F.F.6
-
8
-
-
34748925888
-
Gambogic acid inhibits the catalytic activity of human topoisomerase IIA by binding to its ATPase domain
-
Qin YX, Meng LH, Hu Chaoxin, Duan WH, Zuo ZL, Lin LP, et al. Gambogic acid inhibits the catalytic activity of human topoisomerase IIA by binding to its ATPase domain. Mol Cancer Ther 2007; 6:2429-2440.
-
(2007)
Mol Cancer Ther
, vol.6
, pp. 2429-2440
-
-
Qin, Y.X.1
Meng, L.H.2
Hu, C.3
Duan, W.H.4
Zuo, Z.L.5
Lin, L.P.6
-
9
-
-
51749101694
-
Gambogic acid induced tumor cell apoptosis by T lymphocyte activation in H22 transplanted mice
-
Gu HY, You QD, Liu W, Yang Y, Zhao L, Qi Q, et al. Gambogic acid induced tumor cell apoptosis by T lymphocyte activation in H22 transplanted mice. Int Immunopharmacol 2008; 8:1493-1502.
-
(2008)
Int Immunopharmacol
, vol.8
, pp. 1493-1502
-
-
Gu, H.Y.1
You, Q.D.2
Liu, W.3
Yang, Y.4
Zhao, L.5
Qi, Q.6
-
11
-
-
13544254423
-
Transferrin: Structure, function and potential therapeutic actions
-
Gomme PT, McCann KB, Bertolini J Transferrin: structure, function and potential therapeutic actions. Drug Discov Today, 2005; 10 :267-273.
-
(2005)
Drug Discov Today
, vol.10
, pp. 267-273
-
-
Gomme, P.T.1
McCann, K.B.2
Bertolini, J.3
-
12
-
-
33744981826
-
Altered iron metabolism, transferring receptor 1 and ferritin in patients with colon cancer
-
Prutki M, Poljak-Blazi M, Jakopovic M, Tomas D, Stipancic I, Zarkovic N. Altered iron metabolism, transferring receptor 1 and ferritin in patients with colon cancer. Cancer Lett 2006; 238:188-196.
-
(2006)
Cancer Lett
, vol.238
, pp. 188-196
-
-
Prutki, M.1
Poljak-Blazi, M.2
Jakopovic, M.3
Tomas, D.4
Stipancic, I.5
Zarkovic, N.6
-
13
-
-
33750008791
-
The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer
-
Daniels TR, Delgado T, Rodriguez JA, Helguera G, Penichet ML. The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin Immunol 2006; 121:144-158.
-
(2006)
Clin Immunol
, vol.121
, pp. 144-158
-
-
Daniels, T.R.1
Delgado, T.2
Rodriguez, J.A.3
Helguera, G.4
Penichet, M.L.5
-
14
-
-
34548679604
-
Differential apoptotic induction of gambogic acid, a novel anticancer natural product, on hepatoma cells and normal hepatocytes [J]
-
Yang Y, Yang L, You QD, et al. Differential apoptotic induction of gambogic acid, a novel anticancer natural product, on hepatoma cells and normal hepatocytes [J]. Cancer Lett 2007;256:259-66.
-
(2007)
Cancer Lett
, vol.256
, pp. 259-266
-
-
Yang, Y.1
Yang, L.2
You, Q.D.3
-
15
-
-
35349029248
-
Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF induced apoptosis through modulation of the nuclear factor-(kappa}B signaling pathway
-
Pandey MK, Sung B, Ahn KS, Kunnumakkara AB, Chaturvedi MM, Aggarwal BB. Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF induced apoptosis through modulation of the nuclear factor-(kappa}B signaling pathway. Blood 2007; 110:3517-3525.
-
(2007)
Blood
, vol.110
, pp. 3517-3525
-
-
Pandey, M.K.1
Sung, B.2
Ahn, K.S.3
Kunnumakkara, A.B.4
Chaturvedi, M.M.5
Aggarwal, B.B.6
-
16
-
-
0037009370
-
Caspase 10 is recruited to and activated at the native TRAIL and CD95 death-inducing signaling complexes in a FADD-dependent manner but can not functionally substitute caspase-8
-
Sprick MR, Rieser E, Stahl H, Grosse-Wilde A, Weigand MA, Walczak H. Caspase 10 is recruited to and activated at the native TRAIL and CD95 death-inducing signaling complexes in a FADD-dependent manner but can not functionally substitute caspase-8. EMBO J 2002; 21:4520-4530.
-
(2002)
EMBO J
, vol.21
, pp. 4520-4530
-
-
Sprick, M.R.1
Rieser, E.2
Stahl, H.3
Grosse-Wilde, A.4
Weigand, M.A.5
Walczak, H.6
-
17
-
-
0035923653
-
Caspase 10 is an initiator caspase in death receptor signaling
-
Wang J, Chun HJ, Wong W, Spencer DM, Lenardo MJ. Caspase 10 is an initiator caspase in death receptor signaling. Proc Natl Acad Sci USA 2001;98:13884-13888.
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 13884-13888
-
-
Wang, J.1
Chun, H.J.2
Wong, W.3
Spencer, D.M.4
Lenardo, M.J.5
-
18
-
-
15144345497
-
Pro-caspase-3 is a major physiologic target of caspase-8
-
Stennicke HR, Jurgensmeier JM, Shin H, Deveraux Q, Wolf BB, Yang X, et al. Pro-caspase-3 is a major physiologic target of caspase-8. J Biol Chem 1998;273:27084-27090.
-
(1998)
J Biol Chem
, vol.273
, pp. 27084-27090
-
-
Stennicke, H.R.1
Jurgensmeier, J.M.2
Shin, H.3
Deveraux, Q.4
Wolf, B.B.5
Yang, X.6
|